Showing all 2 results
Antacid & Anti-Ulcerant Tablets
FreeTechnical & Logistics Specifications
Parameter Specifications & Standards HS Code 3004.90.99 (Medicaments acting on the alimentary tract and metabolism) Pharmacopeia Compliance IP / BP / USP / EP Dosage Formats Enteric-Coated, Delayed-Release, Film-Coated, and Chewable Tablets Export Packaging 10 / 14 / 15 Tablets per Blister packed exclusively in high-barrier Alu-Alu (Cold-Form Foil) or thick PVC/PVDC matrixes to protect against moisture ingress in Zone IVb tropical climates. Shelf-Life Stability Fully validated 36-Month real-time stability metrics Mebeverine Tablet
FreeProduct Composition & Available Formats
We supply Mebeverine Hydrochloride in both rapid-acting immediate-release and advanced continuous-release configurations to accommodate customized patient compliance tracking.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mebeverine Hydrochloride IP / BP / USP 135 mg Oral Solid Immediate-Release Film-Coated Tablet Targeted Acute Dosing: Fast-acting formulation designed for standard three-times-daily administration prior to localized food triggers. Mebeverine Hydrochloride IP / BP / USP 200 mg SR Sustained-Release Hydrophilic Polymer Matrix Tablet / Capsule Continuous 24-Hour Coverage: Premium, once- or twice-daily formulation engineered to release active molecules continuously, eliminating nocturnal spikes and maximizing compliance.


